Preformulation Studies
On this page
Direct answer
Preformulation is the investigation of a drug's physicochemical properties before any dosage form is designed, so that formulation proceeds from data rather than trial and error. The scientist builds a solubility profile across the physiological pH range, measures pKa and partition coefficient, characterises the crystal form (polymorphs, hydrates, amorphous content), particle size and flow behaviour, then checks drug-excipient compatibility by differential scanning calorimetry (DSC) and stressed binary mixtures assayed by HPLC. Every major formulation decision — salt versus free acid, wet versus dry granulation, the need for micronisation or a solubiliser — traces back to these numbers, which is why examiners treat preformulation as the foundation chapter of pharmaceutics.
What you must remember
- Solubility and BCS: classes run I (high solubility, high permeability) to IV; Class II drugs are dissolution-limited and prime candidates for enhancement; high solubility commonly means the highest dose dissolving in about 250 mL across pH 1 to 6.8.
- Ionisation: by the Henderson-Hasselbalch relation a weak acid is half unionised when pH equals pKa; absorption favours the unionised lipophilic form — the pH-partition hypothesis.
- Partition coefficient: log P (octanol/water) near 1 to 3 favours passive absorption; far above 5, water solubility collapses and protein binding climbs.
- Polymorphism: different crystal packs of one molecule; the metastable form is more soluble — carbamazepine dihydrate and the ritonavir form II episode are the classics; amorphous dissolves fastest but crystallises on storage.
- Solid-state toolkit: DSC for transitions, thermogravimetric analysis for hydrates, hot-stage microscopy, X-ray powder diffraction as the confirmatory fingerprint.
- Flow indices: angle of repose below about 30 degrees excellent and above 40 poor; Carr's index under about 15 per cent and Hausner ratio under about 1.25 predict direct-compression suitability.
- Compatibility and stability: 1:1 drug-excipient blends screened by DSC and after storage at 40 °C with 75 per cent relative humidity, assayed by HPLC; hydrolysis (aspirin), oxidation (adrenaline) and photolysis (nifedipine) dictate packaging and process.
From data sheet to dosage form
Take a weakly basic molecule returning from preformulation: solubility 0.05 mg/mL at pH 6.8 but good below pH 4, log P near 4, stable polymorph form I, Carr's index 28 per cent, and a DSC interaction with magnesium stearate. Read the formulation out of the numbers. Because dissolution in the intestine will be rate-limiting — Class II behaviour — micronisation or a solid dispersion enters the plan. Poor flow rules out direct compression, pointing to wet granulation; the base is hydrolysis-stable, so a binder solution is safe. The stearate interaction removes magnesium stearate from the lubricant list, replaced by stearic acid or talc. Log P near 4 warns of poor wettability, so a surfactant appears at low level and in the dissolution medium of the specification. One page of data has fixed the manufacturing route, the excipient list and the analytical method — precisely the logic a viva examiner wants articulated.
The traps that cost marks
The commonest slip is confusing polymorphs with pseudopolymorphs: a hydrate or solvate incorporates solvent into the lattice — a different solid species showing mass loss on thermogravimetric analysis, not merely a different packing. The second is quoting angle-of-repose thresholds as gospel; textbook bands differ slightly, so write "about 30 degrees" and never invent a value for a named drug. Finally, candidates write "DSC proves compatibility"; it does not. An unchanged thermogram only suggests no interaction — degradation may be kinetic and invisible until the stressed blend is assayed by HPLC weeks later, so honest conclusions layer thermal, chromatographic and stability data before an excipient is cleared.
Frequently asked questions
Why is solubility measured across a pH range rather than in water alone?
A drug travels from gastric acid near pH 1 to intestinal fluid near pH 6.8, and a weak electrolyte's solubility shifts by orders of magnitude along the way, so a single water value predicts nothing about where dissolution occurs.
How does a polymorph differ from a hydrate?
A polymorph is a different packing of the same molecule, whereas a hydrate or solvate incorporates water or solvent into its crystal lattice — a pseudopolymorph detectable by mass loss on thermogravimetric analysis.
Which preformulation technique screens excipient compatibility fastest?
DSC of 1:1 drug-excipient mixtures, because a shifted, broadened or new melting endotherm flags a likely interaction within hours, though HPLC assay of stressed blends must confirm it.
What Carr's index supports direct compression?
Values below about 15 per cent indicate good flow and compressibility; above roughly 25 to 30 the blend must be granulated before it feeds a tablet press uniformly.
Why does micronisation help a BCS Class II drug?
Class II drugs are dissolution-limited, and reducing particle size raises specific surface area proportionally, increasing dissolution rate and bioavailability without changing solubility itself.